Between 1981 and 2000, 6609 children (<18 years of age) were treated in five consecutive trials of the Berlin–Frankfurt–Münster (BFM) study group for childhood acute lymphoblastic leukemia (ALL).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback